Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Dacoplice Dacomitinib 30mg Tablets:
Dacoplice Dacomitinib 30mg Tablets are a potent treatment option for non-small cell lung cancer (NSCLC). Dacomitinib, the active ingredient, is effective in targeting and managing NSCLC in both smokers and non-smokers.
Uses of Dacoplice Dacomitinib 30mg Tablets:
Dacoplice Dacomitinib 30mg Tablets are used for:
Treating non-small cell lung cancer (NSCLC)
May be administered alone or in combination with other medications
Benefits of Dacoplice Dacomitinib 30mg Tablets:
Mechanism of Action of Dacoplice Dacomitinib 30mg Tablets:
Dacoplice Dacomitinib 30mg Tablets work by inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase. This inhibition prevents the activation of key signaling pathways that promote cancer cell proliferation and survival, thereby slowing down or stopping the growth of cancer cells in NSCLC.